Suppr超能文献

2019年冠状病毒病(COVID-19)患者复查逆转录聚合酶链反应(RT-PCR)结果呈阳性与阴性的临床特征比较:一项来自南京的数据回顾性研究

Comparison of clinical characteristics between patients with coronavirus disease 2019 (COVID-19) who retested RT-PCR positive versus negative: a retrospective study of data from Nanjing.

作者信息

Liu Yuan, Ding Ning, Zhou Shixiang, Chen Chen, Huang Shan, Lv Yanling, Jiao Damin, Zheng Yishan, Hu Zhiliang, Xu Chuanjun, Chen Wei, Dai Hui, Sun Wenkui, Cheng Cong, Lv Ru, Cheng Jian, Ye Zi, Li Zhengjie, Yi Yongxiang, Wei Hongxia

机构信息

Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China.

Department of Respirology and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University; Nanjing, China.

出版信息

J Thorac Dis. 2020 Nov;12(11):6435-6445. doi: 10.21037/jtd.2020.04.17.

Abstract

BACKGROUND

The epidemiological and clinical characteristics of patients with coronavirus disease 2019 (COVID-19) have been reported. However, the prevalence of retesting positive by RT-PCR for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the associated patient characteristics, remain unclear.

METHODS

We included 90 confirmed cases of COVID-19 treated in the Nanjing Public Health Center from January 20, 2020 to February 16, 2020 in this retrospective study. All patients completed treatment for COVID-19 and were retested by RT-PCR for SARS-CoV-2 4-20 days after completion of therapy. The clinical characteristics between patients with who retested positive versus negative by RT-PCR were compared, and the factors predictive of positive retesting were analyzed. Positive retesting was modeled with the area under the receiver operating characteristic curve (AUC).

RESULTS

The age range of the study population was 0.8-97 years, and all patients were cured or showed improvement. A total of 10 (11%) patients retested positive by RT-PCR 4-20 days after completion of therapy. As compared with patients who retested negative, those who retested positive had a lower percentage of pre-admission fever, a higher percentage of post-admission fever, a lower percentage of bilateral lung infection, higher white blood cell (WBC) count and creatine phosphokinase, and lower hypersensitive c-reactive protein (hs-CRP), interleukin-6 and erythrocyte sedimentation rates (all P<0.05). Logistic regression analysis of the above eight key variables showed that lower hs-CRP and higher WBC were independently associated with positive retesting by RT-PCR. A combination of hs-CRP and WBC were predictive of positive retesting, with an AUC of 0.859.

CONCLUSIONS

Patients with COVID-19 who retested positive by RT-PCR for SARS-CoV-2 had mild symptoms and better blood testing results. A combination of hs-CRP and WBC may predict positive retesting by RT-PCR; however, the sensitivity and specificity should be studied further.

摘要

背景

2019年冠状病毒病(COVID-19)患者的流行病学和临床特征已有报道。然而,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)逆转录聚合酶链反应(RT-PCR)复阳率及其相关患者特征仍不清楚。

方法

本回顾性研究纳入了2020年1月20日至2020年2月16日在南京市公共卫生中心接受治疗的90例确诊COVID-19病例。所有患者均完成COVID-19治疗,并在治疗结束后4至20天接受SARS-CoV-2的RT-PCR复测。比较RT-PCR复测阳性和阴性患者的临床特征,并分析预测复测阳性的因素。采用受试者操作特征曲线(AUC)下面积对复测阳性进行建模。

结果

研究人群年龄范围为0.8至97岁,所有患者均治愈或病情好转。共有10例(11%)患者在治疗结束后4至20天RT-PCR复测呈阳性。与复测阴性的患者相比,复测阳性的患者入院前发热百分比更低,入院后发热百分比更高,双侧肺部感染百分比更低,白细胞(WBC)计数和肌酸磷酸激酶更高,超敏C反应蛋白(hs-CRP)、白细胞介素-6和红细胞沉降率更低(均P<0.05)。对上述八个关键变量进行逻辑回归分析表明,较低的hs-CRP和较高的WBC与RT-PCR复测阳性独立相关。hs-CRP和WBC联合可预测复测阳性,AUC为0.859。

结论

SARS-CoV-2的RT-PCR复测呈阳性的COVID-19患者症状较轻,血液检测结果较好。hs-CRP和WBC联合可能预测RT-PCR复测阳性;然而,其敏感性和特异性有待进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7711384/656aac5b94de/jtd-12-11-6435-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验